MMRGlobal Biotech Assets in Play as Company Is Awarded Second U.S. Cancer Fighting Patent
LOS ANGELES, CA — (Marketwired) — 02/02/15 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that U.S. Patent No. 8,945,550 will issue on February 3, 2015, providing the second U.S. patent, in addition to patents in Australia, Mexico and South Korea, for the Company–s anti-CD20 monoclonal antibody technology. MMR also announced that it is in talks to sell more than 2,000 patient
